2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

506. Bone Marrow Microenvironment: Poster II

Program: Poster Abstract Session
Sunday, December 13, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Imaging, Omics Technologies, Bioinformatics, Computational Biology, Profiling, Biological Processes, Pathogenesis, Hematopoiesis, Molecular Biology, Multi-Systemic Interactions, Diseases, Lymphoid Malignancies, Lymphoid Leukemias, Myeloid Malignancies, Acute Myeloid Malignancies, Chronic Myeloid Malignancies, ALL, Research, Fundamental Science, AML, Translational Research, CML, Study Population, Human, Pediatric
PAPER

3155 Coagulation factor VIII (FVIII) together with platelet αIIbβ3 maintains hematopoietic and immune homeostasis

Hongyin Yu, MS, Jocelyn A Schroeder2, Ryan Besserud3, Saurabh Kumar4, Demin Wang, PhD5, Calvin B. Williams6, Qizhen Shi, MD, PhD7
1 Depts of Pediatrics and CBNA, Medical College of Wisconsin, Milwaukee, Wisconsin, United States, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States
2 Depts of Pediatrics and CBNA, Medical College of Wisconsin, Milwaukee, Wisconsin, United States, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States
3 Depts of Pediatrics, Immunology & Microbiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
4 Versiti Blood Research Institute, Milwaukee, Wisconsin, United States
5 Versiti Blood Research Institute, Milwaukee, Wisconsin, United States
6 Depts of Pediatrics, Immunology & Microbiology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
7 Depts of Pediatrics and CBNA, Medical College of Wisconsin, Milwaukee, Wisconsin, United States, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States

Although FVIII and platelet αIIbβ3 (GPIIbIIIa) are classically studied in coagulation and thrombosis, accumulating evidence suggests coagulation-dependent platelet signaling also plays roles in vascular and tissue homeostasis. Since FVIII-dependent thrombin generation needs functional platelet GPIIb signaling, we investigated whether disrupting the FVIII-platelet GPIIb axis affects hematopoietic homeostasis.

We performed bone marrow transplantation (BMT) from αIIbnull into lethally irradiated F8null mice to establish an αIIb- and FVIII-deficient (αIIbnull/F8null) model. αIIbnull/F8null recipients had 50% lethality by week (wk) 3 and 100% by wk 12. No lethality was seen in F8null mice receiving WT-BMT (WT/F8null) or F9null mice with αIIbnull-BMT (αIIbnull/F9null) controls at 3 wks post-BMT. Lethality in αIIbnull/F8null mice was rescued by daily infusion of rhF8 or rhF7. Blood samples collected at 3 wks showed that RBC, Hb, and platelet (Plt) counts were significantly lower in αIIbnull/F8null than in WT/F8null and WT/WT groups. The WBC count was less affected. Compared to αIIbnull/F8null recipients, infusion of rhF8, but not rhF7, significantly restored RBC and Plt counts and Hb levels. Notably, in αIIbnull/F8null recipients receiving rhF8, RBC count improved more than Hb levels (P<.0001 vs P<.01) compared to those without rhF8, indicating a defect in erythroid maturation rather than hemorrhage.

To assess the impact of disrupting the FVIII-GPIIb axis on WBCs, we used FACS to analyze WBC subsets in blood at 3 wks post-BMT. The percentages (%) and totals of CD4, CD8, and B cells in the αIIbnull/F8null (No F8) group were significantly lower than in the WT/WT, WT/F8null, and αIIbnull/F9null controls, with B cells particularly reduced. The %, but not the total number, of myeloid cells (CD11b+) in the αIIbnull/F8null group was significantly higher than in the control groups, demonstrating that both T- and B-cell lineages are impaired, whereas the myeloid lineage is preserved in αIIbnull/F8null mice. Infusion of rhF8, but not rhF7, significantly increased T and B cells and reduced CD11b+ cells. We then evaluated B cell development in BM by FACS analysis of cell stages. In αIIbnull/F8null recipients, most B cells remained at early stages (95%), significantly higher than in WT (62%) and αIIbnull/F8null+rhF8 (67%) groups. Because the thymus is essential for T cell development, we assessed if disruption of FVIII-GPIIb affects thymic recovery after BMT. We found that the thymus in αIIbnull/F8null recipients was markedly reduced in size, with a total cell number of (0.3±0,2)x107 per thymus, significantly lower than in the rhF8-infused group [(7±2)x107] but not different from the rhF7-infused group.  FACS analysis showed increased double-negative cells and decreased double-positive cells in αIIbnull/F8null recipients compared to WT mice, with rhF8 infusion rescuing these changes. rhF7 improved development but didn't fully restore it.     

To determine if hematopoietic abnormalities in αIIbnull/F8null recipients originate from defects in αIIbnull HSPCs or the microenvironment, we performed sequential BMT studies. BM from αIIbnull/F8null primary recipients at 3 wks post-BMT was transplanted into irradiated WT secondary recipients. After 3 wks of reconstitution, RBC counts and Hb levels improved compared to αIIbnull/F8null primary recipients, along with recovery of T- and B-cells and normalization of CD11b⁺ cells. These results demonstrate that αIIbnull hematopoietic cells retain the intrinsic capacity to support hematopoiesis when placed in a WT BM niche with normal FVIII. To assess αIIb's role in the FVIII-GPIIb axis on hematopoiesis, mixed BM cells from αIIbnull and WT were transplanted into irradiated F8null recipients. There was a positive correlation between the % of donor αIIbnull-derived CD4, CD8, and B cells in αIIbnull-WBCs and WT-WBC chimerism, and a negative correlation in CD11b+ cells, showing WT GPIIb supports αIIbnull hematopoiesis in F8null recipients. Additionally, a negative correlation exists between the % of B cells, but not CD4 or CD8, in donor WT-derived WBC and αIIbnull-WBC chimerism, with a positive correlation in CD11b+ cells, indicating GPIIb deficiency impairs WT-hematopoiesis when αIIbnull platelets are present.

In conclusion, our data demonstrate that cooperative signaling between the FVIII-dependent pathway and platelet αIIb-mediated mechanisms is required to maintain hematopoietic and immune homeostasis.

Hongyin Yu, MS: No relevant conflicts of interest to declare.